CD8A and neoplasm: TAMs exert a pro-tumor effect, inhibiting antitumor activities by secreting chemokines such as CCL17, CCL18 and CCL22, which attract Tregs cells to tumor sites, compromising the immune responses of CD8 + cytotoxic T cells [63].